[HTML][HTML] Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension
MM Hoeper, DB Badesch, HA Ghofrani… - … England Journal of …, 2023 - Mass Medical Soc
Background Pulmonary arterial hypertension is a progressive disease involving proliferative
remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated …
remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated …
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
MM Hoeper, DB Badesch… - The New England …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Pulmonary arterial hypertension is a progressive disease involving proliferative
remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated …
remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated …
[引用][C] Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
MM Hoeper, DB Badesch, HA Ghofrani… - New england journal …, 2023 - repositorio.usp.br
ReP USP - Detalhe do registro: Phase 3 Trial of Sotatercept for Treatment of Pulmonary
Arterial Hypertension Home About USP Schools USP Schools Escola de Artes, Ciências e …
Arterial Hypertension Home About USP Schools USP Schools Escola de Artes, Ciências e …
[PDF][PDF] Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
MM Hoeper, DB Badesch, HA Ghofrani, JSR Gibbs… - N Engl J …, 2023 - researchgate.net
BACKGROUND Pulmonary arterial hypertension is a progressive disease involving
proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the …
proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the …
[引用][C] Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension
MM Hoeper, DB Badesch, HA Ghofrani, JSR Gibbs… - 2023 - ruj.uj.edu.pl
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
MM Hoeper, DB Badesch, HA Ghofrani… - The New England …, 2023 - europepmc.org
Background Pulmonary arterial hypertension is a progressive disease involving proliferative
remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated …
remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated …
[引用][C] Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
M Hoeper, D Badesch, HA Ghofrani… - New England Journal …, 2023 - hal.science
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension - Archive
ouverte HAL Accéder directement au contenu Documentation FR Français (FR) Anglais (EN) …
ouverte HAL Accéder directement au contenu Documentation FR Français (FR) Anglais (EN) …
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
MM HOEPER, DB BADESCH… - … England Journal of …, 2023 - observatorio.fm.usp.br
BACKGROUNDPulmonary arterial hypertension is a progressive disease involving
proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the …
proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the …
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
MM Hoeper, DB Badesch, HA Ghofrani… - New England Journal …, 2023 - cir.nii.ac.jp
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[HTML][HTML] Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
MM Hoeper, DB Badesch… - The New England …, 2023 - hsrc.himmelfarb.gwu.edu
BACKGROUND: Pulmonary arterial hypertension is a progressive disease involving
proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the …
proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the …